Natixis Purchases 100,874 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Natixis increased its position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 3,691.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 103,607 shares of the company's stock after buying an additional 100,874 shares during the period. Natixis owned 0.05% of DocuSign worth $9,318,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. FMR LLC lifted its position in DocuSign by 178.2% during the 4th quarter. FMR LLC now owns 6,101,024 shares of the company's stock worth $548,726,000 after acquiring an additional 3,908,139 shares during the last quarter. American Century Companies Inc. boosted its stake in DocuSign by 18.5% during the 4th quarter. American Century Companies Inc. now owns 5,315,459 shares of the company's stock valued at $478,072,000 after purchasing an additional 831,611 shares during the period. Renaissance Technologies LLC boosted its stake in DocuSign by 4.9% during the 4th quarter. Renaissance Technologies LLC now owns 4,363,292 shares of the company's stock valued at $392,434,000 after purchasing an additional 205,304 shares during the period. Geode Capital Management LLC grew its holdings in DocuSign by 7.2% in the 4th quarter. Geode Capital Management LLC now owns 3,732,363 shares of the company's stock valued at $335,147,000 after buying an additional 249,179 shares during the last quarter. Finally, Invesco Ltd. increased its position in DocuSign by 283.9% in the 4th quarter. Invesco Ltd. now owns 3,447,275 shares of the company's stock worth $310,048,000 after buying an additional 2,549,310 shares during the period. 77.64% of the stock is owned by institutional investors.

DocuSign Stock Down 1.3 %

NASDAQ:DOCU opened at $75.42 on Monday. The firm has a market cap of $15.27 billion, a PE ratio of 15.55, a price-to-earnings-growth ratio of 6.94 and a beta of 1.20. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86. The company's 50-day moving average price is $81.35 and its two-hundred day moving average price is $83.38.

DocuSign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. During the same period in the previous year, the business earned $0.76 EPS. DocuSign's revenue was up 9.0% compared to the same quarter last year. On average, research analysts expect that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Wall Street Analyst Weigh In

DOCU has been the subject of several research reports. Bank of America reduced their price objective on DocuSign from $112.00 to $98.00 and set a "neutral" rating for the company in a research report on Friday, March 14th. Wedbush restated a "neutral" rating and set a $100.00 price objective on shares of DocuSign in a report on Friday, March 14th. Hsbc Global Res upgraded shares of DocuSign from a "moderate sell" rating to a "hold" rating in a research note on Friday, April 11th. JMP Securities restated a "market outperform" rating and set a $124.00 price target on shares of DocuSign in a research note on Thursday. Finally, Citigroup raised their price objective on DocuSign from $113.00 to $115.00 and gave the stock a "buy" rating in a research report on Friday, March 14th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $93.08.

Insider Transactions at DocuSign

In other DocuSign news, Director Teresa Briggs sold 534 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the transaction, the director now owns 8,270 shares of the company's stock, valued at approximately $722,880.70. This represents a 6.07 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the firm's stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $86.90, for a total value of $695,200.00. Following the completion of the transaction, the chief financial officer now owns 77,851 shares in the company, valued at approximately $6,765,251.90. This represents a 9.32 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 55,851 shares of company stock worth $4,607,439. Insiders own 1.66% of the company's stock.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.